multiple myeloma

Showing 26 - 50 of 1,882

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Positive Rate of M Protein Based onHighly Sensitive Serum M

Recruiting
  • Multiple Myeloma
  • M Protein
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Oct 9, 2023

    Multiple Myeloma Trial in Boston (THRIVE-M)

    Not yet recruiting
    • Multiple Myeloma
    • THRIVE-M
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 2, 2023

    Based on Quantitative Pharmacology in Patients With Lenalidomide

    Recruiting
    • Multiple Myeloma
    • +2 more
      • Jinan, Shandong, China
        the First Affiliated Hospital of Shandong First Medical Universi
      Oct 3, 2023

      Multiple Myeloma Trial in Wuhan (SENL103)

      Recruiting
      • Multiple Myeloma
      • SENL103
      • Wuhan, Hubei, China
        Tongji Hospital
      Sep 27, 2023

      Multiple Myeloma Trial in United States (Talquetamab)

      Recruiting
      • Multiple Myeloma
      • Basking Ridge, New Jersey
      • +6 more
      Sep 27, 2023

      Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

      Recruiting
      • Multiple Myeloma
        • Annecy, France
        • +19 more
        Sep 28, 2023

        Chronic Leukemia, Hematopoietic and Lymphoid System Tumor, Lymphoma Trial in Scottsdale, Rochester (procedure, behavioral,

        Recruiting
        • Chronic Leukemia
        • +4 more
        • Acupuncture Therapy
        • +15 more
        • Scottsdale, Arizona
        • +1 more
        Sep 29, 2023

        Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

        Not yet recruiting
        • Multiple Myeloma
        • Immediate yoga intervention
        • Delayed yoga intervention
        • Tucson, Arizona
          University of Arizona Cancer Center
        Sep 27, 2023

        Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

        Recruiting
        • Lymphoma
        • Multiple Myeloma
        • pegylated recombinant human granulocyte-colony stimulating factor
        • Chongqing, Chongqing, China
          Chongqing University Cancer Hospital
        Sep 23, 2023

        Multiple Myeloma Trial in Montréal (Elranatamab)

        Not yet recruiting
        • Multiple Myeloma
        • Montréal, Quebec, Canada
          McGill University Health Centre
        Sep 21, 2023

        Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

        Not yet recruiting
        • Multiple Myeloma
        • idecabtagene vicleucel
        • +3 more
        • Gilbert, Arizona
        • +107 more
        Sep 26, 2023

        B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric

        Recruiting
        • B-Cell Non-Hodgkin Lymphoma
        • Multiple Myeloma
        • Best Practice
        • +5 more
        • Duarte, California
          City of Hope Medical Center
        Sep 19, 2023

        Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)

        Recruiting
        • Multiple Myeloma
        • Biospecimen Collection
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Sep 21, 2023

        New Echocardiographic Indicators in Treatment of Primary

        Not yet recruiting
        • Multiple Myeloma
        • Chemotherapy and/or autologous hematopoietic stem cell transplantation
        • (no location specified)
        Sep 18, 2023

        Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

        Recruiting
        • Multiple Myeloma
        • Plasma Cell Leukemia
        • Human BCMA targeted CAR-NK cells injection
        • Shanghai, Shanghai, China
          Shanghai Changzheng Hospital
        Sep 13, 2023

        Multiple Myeloma Trial in Philadelphia (Planned Notification, Survey Administration, Behavioral Intervention)

        Recruiting
        • Multiple Myeloma
        • Planned Notification
        • +4 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Sep 11, 2023

        Multiple Myeloma Trial in Rochester (procedure, biological, drug)

        Not yet recruiting
        • Multiple Myeloma
        • Biospecimen Collection
        • +12 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Sep 15, 2023

        Real-World Mapping Antithrombotic Regimens in MM Patients on

        Not yet recruiting
        • Multiple Myeloma
        • Diagnosis
          • (no location specified)
          Aug 31, 2023

          Multiple Myeloma Trial (Elranatamab)

          Not yet recruiting
          • Multiple Myeloma
          • (no location specified)
          Aug 28, 2023

          Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

          Recruiting
          • Multiple Myeloma
          • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
          • Wuhan, Hubei, China
            Union Hospital, Tongji Medical College, Huazhong University of S
          Aug 11, 2023

          Multiple Myeloma Trial in São Paulo (Single-dose involved-site radiotherapy)

          Recruiting
          • Multiple Myeloma
          • Single-dose involved-site radiotherapy
          • São Paulo, Sao Paulo, Brazil
            University of Sao Paulo
          Aug 9, 2023

          Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

          Not yet recruiting
          • Multiple Myeloma
          • Bone marow biopsy and aspiration
          • biochemical and heamatological tests
          • (no location specified)
          Aug 9, 2023

          Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory

          Not yet recruiting
          • Multiple Myeloma
          • Durham, North Carolina
            Duke University Medical Center
          Aug 8, 2023

          Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

          Recruiting
          • Breast Cancer
          • +4 more
          • Web based survey
          • New Haven, Connecticut
          • +6 more
          Aug 8, 2023